Recent News
On September 23, 2025 shares moved lower amid broad market weakness and above-average volume. On September 22, 2025 the stock outperformed on a strong trading day, reversing a short losing streak. On September 17, 2025 shares declined with volume above recent averages. Reports focused on daily trading performance and elevated volume, without new corporate guidance or material corporate actions.
Technical Analysis
Directional indicators (ADX / DI+ / DI-): ADX at 56.15 signals very strong trend strength; DI- at 39.85 and increasing indicates sellers controlling directional momentum while DI+ at 6.59 and decreasing confirms weakening buyer presence. That combination aligns with a pronounced bearish price bias against the current valuation.
MACD: MACD at -21.14 and declining with a signal line at -14.44 shows bearish momentum and ongoing downward pressure; no MACD crossover above the signal line appears, which keeps momentum confirmation in the sellers’ favor for the near term.
MRO (Momentum/Regression Oscillator): MRO at -28.83 sits below zero, indicating price below modeled target and signaling potential for upward reversion toward the valuation reference. That reading provides counterweight to the prevailing momentum and suggests bounce risk while sellers dominate trend strength.
RSI: RSI at 32.5 and decreasing points toward oversold territory and persistent selling pressure; the low RSI supports the possibility of short-term relief rallies but does not negate the dominant downtrend signaled by ADX and DI-.
Price vs. moving averages and bands: Closing price at $288.41 falls well beneath the 200-day average of $431.38 and below the 50-day average of $379.03, reinforcing long-term and medium-term weakness versus the valuation reference. Price sits near the 52-week low range ($288.84 low, $495.04 high), remaining close to lower Bollinger boundaries (1x lower band $303.88, 2x lower band $266.13), indicating elevated downside volatility but scope for reversion toward the mean target.
Volume and volatility context: Recent volume (about 999,930) trails the 10-day average of 1,066,377 but exceeds longer averages, and 42- and 52-week volatilities at 2% show relatively muted realized volatility versus the strong directional move; the combination suggests conviction in recent selling but potential for sharp moves if momentum changes.
Fundamental Analysis
Profitability and earnings: Reported EPS at $4.05 missed the estimate of $4.13 by $0.08, an EPS surprise of -1.94%. Trailing earnings growth reads -5.15% while quarter-over-quarter earnings growth shows 2,101.71% and year-over-year earnings growth shows -64.26%; those figures indicate substantial short-term fluctuation that will require further context from future reporting cycles.
Valuation multiples: Trailing PE equals 96.87x; forward PE equals 87.09x; PEG ratio stands at -18.80, with forward PEG at -16.90. Those multiples position the stock at elevated earnings multiples relative to typical market norms and reflect analysts’ expectations embedded in forward earnings estimates and long-term growth assumptions.
Revenue and cash flow: Reported revenue growth shows 0.00% with quarter-over-quarter and year-over-year revenue growth both at -100.00%, while cash flow margin and cash flow to earnings both register 0.00%. Those revenue and cash-flow figures require reconciliation with company filings; within the provided metrics, top-line momentum lacks positive contribution to near-term valuation support.
Capital structure and returns: Invested capital equals $1,256,459,000 and cost of debt equals 0.76%. Forward EPS at $4.67 sets a forward earnings base that produces the forward PE noted above. Earnings growth QoQ at 2,101.71% contrasts sharply with YoY declines, creating uneven fundamentals that the current valuation must absorb.
Valuation summary: The current valuation as determined by WMDST corresponds to a mean price target of $282.80. Market price at $288.41 sits marginally above that mean target while technicals signal stronger downside momentum; fundamentals show elevated multiples and mixed growth metrics, creating a tension between momentum-driven price action and target-based valuation.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-08-31 |
| REPORT DATE: | 2025-09-18 |
| NEXT REPORT DATE: | 2025-12-18 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 4.13 | |
| EPS Actual | $ 4.05 | |
| EPS Difference | $ -0.08 | |
| EPS Surprise | -1.937 % | |
| Forward EPS | $ 4.67 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 96.867 | |
| Price To Earnings QoQ | -6.052 % | |
| Price To Earnings YoY | -13.849 % | |
| Price To Earnings IPRWA | — | |
| PE/G Ratio | -18.802 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 87.094 | |
| Forward PE/G | -16.905 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ 1.3 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.76 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | — | |
| Earnings Growth | -5.152 % | |
| Earnings Growth QoQ | 2101.709 % | |
| Earnings Growth YoY | -64.262 % | |
| Earnings Growth IPRWA | — | |
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |